Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide

International Journal of Molecular Medicine

Volumn 36, Issue 1, 2015, Pages 43-52

  Zhou, Yunchuan ^a   Zhou, Yang ^a   Yu, Shanshan ^a   Wu, Jingxian ^a   Chen, Yanlin ^a   Zhao, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Astrocytes; Neuroprotection; Sulfiredoxin 1

Indexed keywords

ANTIOXIDANT; CASPASE 12; CASPASE 3; CASPASE 9; CYTOCHROME C; HYDROGEN PEROXIDE; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN DERIVATIVE; SULFIREDOXIN 1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, RAT; CASP12 PROTEIN, RAT; GLUCOSE; LACTATE DEHYDROGENASE; OXIDOREDUCTASE; SMALL INTERFERING RNA; SRXN1 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GLUCOSE METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; OXYGEN GLUCOSE DEPRIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; DEFICIENCY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE; RNA INTERFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; BRAIN ISCHEMIA; CASPASE 12; CASPASE 3; CASPASE 9; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYTOCHROMES C; GLUCOSE; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; POLY(ADP-RIBOSE) POLYMERASES; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84930336473     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2205     Document Type: Article

References (51)

1. Li Q, Yu S, Wu J, Zou Y and Zhao Y: Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide. J Neurosci Res 91: 861-870, 2013.
2. Kinsner A, Pilotto V, Deininger S, et al: Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation. J Neurochem 95: 1132-1143, 2005.
3. Papadia S, Soriano FX, Leveille F, et al: Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11: 476-487, 2008.
4. Biteau B, Labarre J and Toledano MB: ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425: 980-984, 2003.
5. Rhee SG, Jeong W, Chang TS and Woo HA: Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int Suppl 72: S3-S8, 2007.
6. 2-sensing by the antioxidant Pap1 pathway. Proc Natl Acad Sci USA 102: 8875-8880, 2005.
7. Findlay VJ, Tapiero H and Townsend DM: Sulfiredoxin: a potential therapeutic agent? Biomed Pharmacother 59: 374-379, 2005.
8. Soriano FX, Leveille F, Papadia S, et al: Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J Neurochem 107: 533-543, 2008.
9. Kang KW, Lee SJ and Kim SG: Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal 7: 1664-1673, 2005.
10. Singh A, Ling G, Suhasini AN, et al: Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 46: 376-386, 2009.
11. Bell KF, Al-Mubarak B, Fowler JH, et al: Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA 108: E1-E2, 2011.
12. Noh YH, Baek JY, Jeong W, Rhee SG and Chang TS: Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem 284: 8470-8477, 2009.
13. 2. J Biol Chem 287: 81-89, 2012.
14. Wu J, Li Q, Wang X, et al: Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 8: e59843, 2013.
15. Wu X, Zhao J, Yu S, Chen Y, Wu J and Zhao Y: Sulforaphane protects primary cultures of cortical neurons against injury induced by oxygen-glucose deprivation/reoxygenation via antiapoptosis. Neurosci Bull 28: 509-516, 2012.
16. Liu SB, Zhang N, Guo YY, et al: G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci 32: 4887-4900, 2012.
17. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
18. Song S, Zhou J, He S, et al: Expression levels of microRNA-375 in pancreatic cancer. Biomed Rep 1: 393-398, 2013.
19. Lin CJ, Chen TH, Yang LY and Shih CM: Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis 5: e1147, 2014.
20. Han F, Tao RR, Zhang GS, et al: Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells. J Pineal Res 50: 281-291, 2011.
21. Sung DK, Chang YS, Kang S, Song HY, Park WS and Lee BH: Comparative evaluation of hypoxic-ischemic brain injury by flow cytometric analysis of mitochondrial membrane potential with JC-1 in neonatal rats. J Neurosci Methods 193: 232-238, 2010.
22. Zhao J, Kobori N, Aronowski J and Dash PK: Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393: 108-112, 2006.
23. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21: 2-14, 2001.
24. Hossain MA: Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int J Dev Neurosci 26: 93-101, 2008.
25. Kawamura M, Nakajima W, Ishida A, Ohmura A, Miura S and Takada G: Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037: 59-69, 2005.
26. Northington FJ, Graham EM and Martin LJ: Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res Brain Res Rev 50: 244-257, 2005.
27. Stellwagen D and Malenka RC: Synaptic scaling mediated by glial TNF-alpha. Nature 440: 1054-1059, 2006.
28. Perea G, Yang A, Boyden ES and Sur M: Optogenetic astrocyte activation modulates response selectivity of visual cortex neurons in vivo. Nat Commun 5: 3262, 2014.
29. Lopez-Hidalgo M and Schummers J: Cortical maps: a role for astrocytes? Curr Opin Neurobiol 24: 176-189, 2014.
30. Giffard RG and Swanson RA: Ischemia-induced programmed cell death in astrocytes. Glia 50: 299-306, 2005.
31. Yu AC, Wong HK, Yung HW and Lau LT: Ischemia-induced apoptosis in primary cultures of astrocytes. Glia 35: 121-130, 2001.
32. Wang J, Deng X, Zhang F, Chen D and Ding W: ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res Lett 9: 117, 2014.
33. Xie Z, Smith CJ and Van Eldik LJ: Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45: 170-179, 2004.
34. Takuma K, Baba A and Matsuda T: Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72: 111-127, 2004.
35. Desagher S and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 10: 369-377, 2000.
36. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
37. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
38. Ferri KF and Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-E263, 2001.
39. Nakagawa T, Zhu H, Morishima N, et al: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103, 2000.
40. Leist M and Nicotera P: Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res 239: 183-201, 1998.
41. Iijima T, Mishima T, Akagawa K and Iwao Y: Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res 993: 140-145, 2003.
42. Ye R, Li N, Han J, et al: Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 64: 306-310, 2009.
43. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X and Akey CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9: 423-432, 2002.
44. Ji YB, Qu ZY and Zou X: Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol 63: 69-78, 2011.
45. Khan M, Ding C, Rasul A, et al: Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells. Int J Biol Sci 8: 533-547, 2012.
46. Wong WW and Puthalakath H: Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life 60: 390-397, 2008.
47. Moldoveanu T, Follis AV, Kriwacki RW and Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci 39: 101-111, 2014.
48. Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101, 2011.
49. Shacka JJ and Roth KA: Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications. Curr Drug Targets CNS Neurol Disord 4: 25-39, 2005.
50. Szegezdi E, Fitzgerald U and Samali A: Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci 1010: 186-194, 2003.
51. Sergeev IN: Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol 97: 145-151, 2005.